APA (7th ed.) Citation

Schmitt, M. W., Loeb, L. A., & Salk, J. J. (2016). The influence of subclonal resistance mutations on targeted cancer therapy. Nature reviews. Clinical oncology, 13(6), 335-347. https://doi.org/10.1038/nrclinonc.2015.175

Chicago Style (17th ed.) Citation

Schmitt, Michael W., Lawrence A. Loeb, and Jesse J. Salk. "The Influence of Subclonal Resistance Mutations on Targeted Cancer Therapy." Nature Reviews. Clinical Oncology 13, no. 6 (2016): 335-347. https://doi.org/10.1038/nrclinonc.2015.175.

MLA (9th ed.) Citation

Schmitt, Michael W., et al. "The Influence of Subclonal Resistance Mutations on Targeted Cancer Therapy." Nature Reviews. Clinical Oncology, vol. 13, no. 6, 2016, pp. 335-347, https://doi.org/10.1038/nrclinonc.2015.175.